Trial · NCT07903792
Diagnostic Value of Oropharyngeal Suction and Effect of Respiratory Physiotherapy on the Detection of Microorganisms in the Pediatric Patient
NCT07903792, Not applicable, Recruiting, Corporacion Parc Tauli
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Diagnostic Value of Oropharyngeal Suction and Effect of Respiratory Physiotherapy on the Detection of Microorganisms in the Pediatric Patient. Trials, record NCT07903792. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07903792
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Diagnostic Value of Oropharyngeal Suction and Effect of Respiratory Physiotherapy on the Detection of Microorganisms in the Pediatric Patient
- NCT number
- NCT07903792
- Status
- Recruiting
- Phases
- Not applicable
- Enrollment
- 196 participants, estimated
- Lead sponsor
- Corporacion Parc Tauli
- Conditions
- Cystic Fibrosis (CF), Bronchiectasis, Non-Cystic Fibrosis
- Interventions
- Respiratory physiothperapy, Oropharyngeal suction, Oropharyngeal swab, Induced Sputum
- First posted
- 2026-10-29
- Last updated
- 2026-10-29
Source ClinicalTrials.gov
Registered outcomes8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Presence/absence of microorganisms in each sample, as a binary variable | At baseline | To determine the diagnostic efficacy of oropharyngeal suction, the detection of the studied microorganisms in the samples obtained using this method will be evaluated as a binary variable (presence/absence). The microorganisms studied are: * Staphylococcus aureus, methicillin-sensitive (MSSA) and methicillin-resistant (MRSA) * Pseudomonas aeruginosa (PA) * Haemophilus influenzae (HI) * Streptococcus pneumoniae (SP) * Enterobacter cloacae (EC) * Burkholderia cepacia (BC) * Moraxella catarrhalis (MC) * Mycobacterium abscessus (MA) * Aspergillus fumigatus (AF) * Other From these variables, the following derived indicators will be obtained: * Suction vs. induced sputum agreement (percentage agreement and kappa coefficient) * Suction sensitivity * Suction specificity |
| Secondary | Presence/absence of microorganisms in Oropharyngeal Suction and Induced Sputum obtained post-physiotherapy | At baseline | To determine the effect of a physiotherapy session prior to sample collection, the presence/absence of the studied microorganisms in samples obtained by suction and those obtained through induced sputum will be evaluated. The following derived indicators will be compared with those of the group that has NOT undergone prior physiotherapy to determine whether this improves the agreement between the methods: * Suction and induced sputum agreement by group (κ and % agreement) * Sensitivity and specificity stratified by group |
| Secondary | Presence/absence of microorganisms in oropharyngeal swab and oropharyngeal suction | At baseline | To compare the results obtained from samples collected by oropharyngeal swab and those obtained by oropharyngeal suction, the presence or absence of the microorganisms studied will be determined in both samples. The degree of agreement will be calculated as a derived indicator (κ and percentage of agreement). |
| Secondary | Sensitivity and specificity of oropharyngeal suction and oropharyngeal swab compared to induced sputum | At baseline | It will be determined by the proportions of true positives and true negatives, respectively, relative to induced sputum, which is considered the reference method. |
| Secondary | Age | At baseline | Quantitative variable (years), which will be categorized into two subgroups for analysis: children (5-11 years) and adolescents (12-18 years). It will be used as a potential effect modifier in the analysis of diagnostic concordance and response to respiratory physiotherapy. |
| Secondary | Oxygen saturation | Before and immediately after the procedure | Oxygen saturation (as a percentage) to determine safety of the three sample taking methods. |
| Secondary | Heart rate | Before and immediately after the procedure | Heart rate (in beats per minute) will be recorded before and after sample collection to determine the safety of each technique. |
| Secondary | Presence/absence of adverse effects | During the procedure and up to 24 hours post-procedure. | The presence or absence of the following adverse effects will be recorded both during sample collection and on the following day: * Irritative/persistent cough * Vomiting * Nausea * Other (specify) |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers20
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07903792
GET https://conductscience.org/api/trials/v1/NCT07903792/registered